Latin America Cancer Radiation Therapy Market Outlook (2021–2031)

The Latin America cancer radiation therapy market size is expected to reach US$ 7,203.8 million by 2031 from US$ 3,567.0 million in 2024. The market is estimated to record a CAGR of 10.6% from 2025 to 2031.

Executive Summary and Latin America Cancer Radiation Therapy Market Analysis:

The Latin America cancer radiation therapy market is growing steadily as cancer incidence rises and healthcare systems place a stronger focus on oncology treatment. Countries across the region are expanding radiotherapy services within public hospitals and private cancer centers, with Mexico and Brazil leading infrastructure development. Urban hospitals are adopting modern radiation therapy solutions, including advanced linear accelerators and precision treatment-planning systems, to improve treatment accuracy and patient outcomes. Growing awareness of radiation therapy as a core cancer treatment option is also supporting higher referral rates and broader acceptance among patients and clinicians.

Government healthcare programs and partnerships with private providers are helping improve access to radiation therapy in major cities. However, access remains uneven across the region. Rural and remote areas continue to face limited availability of radiotherapy services due to high equipment costs and infrastructure constraints. The market also faces challenges related to a shortage of trained radiation oncologists, medical physicists, and technologists, which can delay treatment and limit equipment utilization. Despite these barriers, ongoing investment in hospital modernization, training initiatives, and technology upgrades continues to support long-term market development across Latin America.

Latin America Cancer Radiation Therapy Market - Strategic Insights:

Latin America Cancer Radiation Therapy Market Segmentation Analysis:

Key segments that contributed to the derivation of the Latin America cancer radiation therapy market analysis are type, cancer type, and end user.

• By type, the cancer radiation therapy market is segmented into external beam radiation therapy and internal beam radiation therapy. The external beam radiation therapy segment dominated the market in 2024.
• Based on cancer type, the cancer radiation therapy market is segmented into lung cancer, breast cancer, colorectal cancer, prostate cancer, head & neck cancer, cervical cancer, and others. The lung cancer segment dominated the market in 2024.
• In terms of end user, the cancer radiation therapy market is segmented into hospitals, specialty clinics, ambulatory and radiotherapy centers, and academic and research institutes. The hospitals segment dominated the market in 2024.

Latin America Cancer Radiation Therapy Market Drivers and Opportunities:

Rising Incidence of Cancer

Cancer incidence across Latin America is increasing steadily owing to an aging population, urbanization, and lifestyle-related risk factors such as tobacco use, dietary changes, and physical inactivity. Breast, prostate, colorectal, cervical, and lung cancers are among the most commonly diagnosed across the region, with countries such as Brazil, Mexico, Argentina, and Colombia accounting for a large share of cases. Improved awareness and expanding screening programs are leading to higher detection rates, increasing demand for radiation therapy services.

Healthcare systems in Latin America are at varying stages of development, creating uneven access to cancer care. Large urban centers have well-established oncology hospitals equipped with external beam radiation therapy systems, while access in rural areas remains limited. Radiation therapy plays a critical role in cancer treatment, particularly where late-stage diagnosis is common, and surgery alone is insufficient. Internal beam radiation therapy is used for cervical and prostate cancers, which are prevalent in several Latin American countries.

Governments and private healthcare providers are investing in cancer care infrastructure to address the rising disease burden. Public, private partnerships, and international collaborations are helping expand radiation oncology capacity and improve patient access. As cancer prevalence continues to rise across Latin America, it remains a strong driver supporting sustained growth in the regional cancer radiation therapy market.

The Growth of Tailored Medicine Solutions

Personalized medicine is gaining momentum in Latin America as clinicians and patients seek more effective and targeted cancer treatments. Advancements in diagnostic imaging and treatment planning are enabling radiation therapy to be tailored to individual patient and tumor characteristics. This shift is creating opportunities for modern external beam radiation therapy techniques that allow precise dose delivery while reducing damage to surrounding healthy tissue.

In external beam radiation therapy, technologies such as intensity-modulated radiation therapy and image-guided approaches are being gradually adopted, particularly in leading hospitals in Brazil, Chile, and Argentina. Internal beam radiation therapy is also becoming more personalized, especially for cervical and prostate cancer treatment, where accurate dose placement is critical for improving outcomes and minimizing complications.

As oncology training improves and access to advanced technologies expands, more cancer centers in Latin America are developing the capability to deliver customized radiation therapy. Patients are informed and are seeking higher-quality treatment options with fewer side effects. This rising demand for personalized medicine presents strong growth opportunities for radiation therapy equipment manufacturers, software providers, and healthcare systems across the Latin American market.

Latin America Cancer Radiation Therapy Market Size and Share Analysis:

The Latin America cancer radiation therapy market demonstrates steady growth, with size and share analysis highlighting evolving trends and competitive dynamics among key players. The report further examines subsegments categorized within type, cancer type, and end user, offering insights into their contribution to overall market performance.

By type, the external beam radiation therapy subsegment dominated the market in 2024. Due to its widespread availability, precision targeting, noninvasive nature, and effectiveness in treating diverse cancers, it is the preferred choice across global oncology practices.

Based on cancer type, the lung cancer subsegment dominated the market in 2024. Due to its high incidence, strong link with smoking and pollution, late‑stage diagnoses, and reliance on advanced radiation techniques, it is the most treated cancer type globally.

In terms of end user, the hospitals subsegment dominated the market in 2024. Hospitals dominated the market since they provide comprehensive cancer care, advanced radiation infrastructure, skilled oncologists, and integrated treatment pathways, making them the primary setting for delivering radiation therapy services.

Latin America Cancer Radiation Therapy Market Report Highlights:

Latin America Cancer Radiation Therapy Market Report Coverage and Deliverables:

The "Latin America Cancer Radiation Therapy Market Size and Forecast (2021 - 2031)" report provides a detailed analysis of the market covering below areas:

• Latin America Cancer Radiation Therapy market size and forecast at regional and country levels for key market segments covered under the scope
• Latin America Cancer Radiation Therapy market trends, as well as market dynamics such as drivers, restraints, and key opportunities
• Latin America Cancer Radiation Therapy market analysis covering key market trends, regional framework, major players, regulations, and recent market developments
• Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Latin America Cancer Radiation Therapy market
• Detailed company profiles, including SWOT analysis

Latin America Cancer Radiation Therapy Market Geographic Insights:

The geographical scope of the Latin America Cancer Radiation Therapy market report is divided into: Brazil, Mexico, Argentina, Colombia, Chile, and Peru. Mexico held the largest share in 2024.

Mexico dominates the Latin America cancer radiation therapy market due to its expanding oncology infrastructure and growing focus on modern cancer treatment delivery. The country has strengthened radiotherapy capacity across major public hospitals and private cancer centers, particularly in large metropolitan regions. Healthcare providers are adopting advanced radiation therapy technologies to support precise tumor targeting and reduce damage to surrounding healthy tissue. This has positioned radiation therapy as a central component of cancer care pathways across the country.

Mexico benefits from increasing collaboration between government healthcare institutions, private hospital networks, and international technology suppliers. These collaborations support equipment upgrades, service availability, and improved maintenance capabilities. The country's leading cancer centers also play an important role in clinical training, helping build a skilled workforce capable of delivering complex radiotherapy procedures. However, gaps remain between urban and rural regions, where access to radiation therapy services is limited. Addressing workforce shortages and expanding infrastructure beyond major cities remain key priorities. Overall, Mexico's continued investment in technology adoption, healthcare modernization, and oncology training reinforces its leadership position in the Latin American radiation therapy market.

Latin America Cancer Radiation Therapy Market Research Report Guidance:

• The report includes qualitative and quantitative data in the Latin America cancer radiation therapy market across type, cancer type, end user, and geography.
• The report starts with the key takeaways (chapter 2), highlighting the key trends and outlook of the Latin America Cancer Radiation Therapy market.
• Chapter 3 includes the research methodology of the study.
• Chapter 4 further includes ecosystem analysis.
• Chapter 5 highlights the major industry dynamics in the Latin America Cancer Radiation Therapy market, including factors that are driving the market, prevailing deterrents, potential opportunities, as well as future trends. Impact analysis of these drivers and restraints is also covered in this section.
• Chapter 6 discusses the Latin America Cancer Radiation Therapy market scenario, in terms of historical market revenues, and forecast till the year 2031.
• Chapters 7 to 10 cover Latin America Cancer Radiation Therapy market segments by type, cancer type, end user, and geography across Brazil, Mexico, Argentina, Colombia, Chile, and Peru. They cover the market revenue, forecast, and factors driving the market.
• Chapter 11 describes the competitive analysis along with the heat map analysis for the key players operating in the market.
• Chapter 12 describes the industry landscape analysis. It provides detailed descriptions of business activities such as market initiatives, new developments, mergers, and joint ventures globally, along with a competitive landscape.
• Chapter 13 provides detailed profiles of the major companies operating in the Latin America Cancer Radiation Therapy market. Companies have been profiled on the basis of their key facts, business descriptions, products, financial overview, SWOT analysis, and key developments.
• Chapter 14, i.e., the appendix, is inclusive of a brief overview of the company, list of abbreviations, and disclaimer.

Latin America Cancer Radiation Therapy Market News and Key Development:

The Latin America Cancer Radiation Therapy market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the key developments in the Latin America cancer radiation therapy market are:

• In February 2025, Elekta announced that it won a public tender from the Instituto Mexicano del Seguro Social (IMSS) to supply eight precision linear accelerators for cancer care across multiple IMSS facilities in Mexico, building on a long-term collaboration to enhance the nation's radiation oncology capacity.
• In August 2024, Elekta announced that it had received a US$ 64 million order from Hospital Angeles Health System in Mexico to supply state-of-the-art linear accelerators (linacs), its Elekta Esprit Gamma Knife system, oncology software, and services as part of a significant expansion of advanced radiation therapy infrastructure in the country.

Key Sources Referred:

• The World Bank
• World Health Organization (WHO)
• Center for Disease Control and Prevention (CDC)
• Union for International Cancer Control (UICC)
• International Agency for Research on Cancer (IARC)
• American Society for Radiation Oncology (ASTRO)
• European Society for Radiotherapy & Oncology (ESTRO)
• Asia-Oceania Federation of Organizations for Radiological Technology (AOFRT)
• Company Websites
• Company Annual Reports
• Company Investor Presentations